IM
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
4.23
Exchange
XNAS - Nasdaq
0.68 B
Last period Equity ,USD
507%
Equity has increased in 4 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also Immunovant
Company Analysis
IMVT valuation, rating, competitors, insights and company profile
Eyestock Rating
IMVT financial analysis by Eyestock methodology
Valuation
IMVT valuation using historical relative method
Statements
IMVT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
IMVT dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
Immunovant`s Equity for the period ended 2023-12-31 is 0.68 B USD
